Leonard Scott Dove

Title: The Innovations of Leonard Scott Dove

Introduction

Leonard Scott Dove is an accomplished inventor based in Driftwood, TX (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of opioid receptor modulators. His work focuses on creating abuse-deterrent solid dosage formulations that aim to improve patient safety and efficacy.

Latest Patents

Dove holds a patent for "Opioid receptor modulator dosage formulations." This patent includes abuse deterrent solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, along with processes for the preparation and administration of these formulations. This innovation is crucial in addressing the ongoing opioid crisis by providing safer medication options.

Career Highlights

Leonard Scott Dove is associated with Allergan Holdings Unlimited Company, where he continues to develop innovative solutions in the pharmaceutical industry. His expertise and dedication to research have positioned him as a valuable asset in his field.

Collaborations

Dove has collaborated with notable colleagues, including Tim Costello and J. Michael Davenport. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical solutions.

Conclusion

Leonard Scott Dove's contributions to the field of opioid receptor modulators exemplify the importance of innovation in pharmaceuticals. His work not only addresses critical health issues but also showcases the potential for advancements in medication safety.